Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Bielsa

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BMC Medical Genomics|March 6, 2015
Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limbElisabeth Castellanos, Isabel Bielsa, Cristina Carrato, et al.
Journal of the American Academy of Dermatology|August 22, 2018
Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patientsIngrid López-Lerma, Yeray Peñate, Fernando Gallardo, et al.
JAMA Dermatology|January 12, 2018
Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in ChildhoodElisabeth Castellanos, Adrià Plana, Cristina Carrato, et al.
Journal of Medical Genetics|August 5, 2021
Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic componentNúria Catasús, Belen Garcia, Iván Galván-Femenía, et al.
Blood Advances|April 12, 2022
Sézary syndrome patient-derived models allow drug selection for personalized therapyFernando Gallardo, Evelyn Andrades, Arnau Iglesias, et al.
Journal of Medical Genetics|February 5, 2022
Neurofibromatosis type 1 families with first-degree relatives harbouring distinct <i>NF1</i> pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?Belen Garcia, Nuria Catasus, Andrea Ros, et al.
Journal of the American Academy of Dermatology|February 15, 2019
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter studyFederica Guicciardi, Laura Atzori, Angelo Valerio Marzano, et al.
European Journal of Dermatology : EJD|December 5, 2022
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?Gemma Melé-Ninot, Esther Serra-Baldrich, Jorge Spertino, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2023
Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter studyMaría Castellanos-Gonzalez, Beatriz Butrón Bris, Isabel Bielsa Marsol, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 18, 2026
Phenotypes and clinical outcomes in children with moderate-to-severe atopic dermatitis across diverse ancestries: a Spanish multicenter observational study and cluster analysis (AD-SKINS Project)Eugeni Prat-Colilles, Adrià Plana-Pla, Asunción Vicente, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Medical Genomics|March 6, 2015
Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limbElisabeth Castellanos, Isabel Bielsa, Cristina Carrato, et al.
Journal of the American Academy of Dermatology|August 22, 2018
Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patientsIngrid López-Lerma, Yeray Peñate, Fernando Gallardo, et al.
JAMA Dermatology|January 12, 2018
Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in ChildhoodElisabeth Castellanos, Adrià Plana, Cristina Carrato, et al.
Journal of Medical Genetics|August 5, 2021
Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic componentNúria Catasús, Belen Garcia, Iván Galván-Femenía, et al.
Blood Advances|April 12, 2022
Sézary syndrome patient-derived models allow drug selection for personalized therapyFernando Gallardo, Evelyn Andrades, Arnau Iglesias, et al.
Journal of Medical Genetics|February 5, 2022
Neurofibromatosis type 1 families with first-degree relatives harbouring distinct <i>NF1</i> pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?Belen Garcia, Nuria Catasus, Andrea Ros, et al.
Journal of the American Academy of Dermatology|February 15, 2019
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter studyFederica Guicciardi, Laura Atzori, Angelo Valerio Marzano, et al.
European Journal of Dermatology : EJD|December 5, 2022
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?Gemma Melé-Ninot, Esther Serra-Baldrich, Jorge Spertino, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2023
Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter studyMaría Castellanos-Gonzalez, Beatriz Butrón Bris, Isabel Bielsa Marsol, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 18, 2026
Phenotypes and clinical outcomes in children with moderate-to-severe atopic dermatitis across diverse ancestries: a Spanish multicenter observational study and cluster analysis (AD-SKINS Project)Eugeni Prat-Colilles, Adrià Plana-Pla, Asunción Vicente, et al.
Pageof 4